CClinicalTrials.gg
Sign In
CompletedNCT05915650Updated Jun 23, 2023

Application of PNE in Postoperative Pain Management of Patients With Primary Total Knee Arthroplasty

An interventional study of Pain Neuroscience Education and Routine Education in Pain, sponsored by Zunyi Medical College. Completed at 1 site in China. Open to participants aged 45 Years to 74 Years. Per ClinicalTrials.gov, last updated 2023-06-23.

Sponsored by Zunyi Medical College · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 6 months after the study started (first participant enrolled Dec 2020, registered Jun 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
45 Years to 74 Years
Sex
All
01

Study summary

This study intends to carry out pain neuroscience education intervention for TKA patients to clarify the effect of this method on the degree of postoperative pain, the incidence of pain catastrophizing, kinesiophobia, and knee joint function rehabilitation in TKA patients, so as to provide a basis for clinical nursing of such patients.

02

Conditions studied

  • Pain

Browse trials for

03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 70 is close to the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Zunyi Medical College is the lead sponsor of 20 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Patients diagnosed as KOA according to the criteria and undergoing unilateral total knee arthroplasty for the first time;
  2. The subjects included in this study were men or women aged 45-74 years;
  3. Clear self-cognition, can browse the text by themselves or can answer questions correctly;
  4. Those who voluntarily participated in the study and signed an informed consent form after understanding the relevant information of the study;
  5. Without serious physical diseases such as heart, liver or kidney;
  6. No history of mental illness or drug dependence.

Exclusion criteria

Exclusion Criteria:

  1. Combined with severe trauma in other parts;
  2. Accompanied by serious damage to other organs, such as heart and cerebrovascular diseases, lung and kidney diseases;
  3. Patients with knee tumor and severe knee deformity who could not complete the rehabilitation;
  4. With neurological diseases that limit physical activity;
  5. Participating in other investigators during the same period.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Pain Neuroscience Education Group

    Behavioral: Pain Neuroscience Education

  • Experimental
    Routine Education Group

    Behavioral: Routine Education

Interventions

  • BehavioralPain Neuroscience Education

    Carry out pain neuroscience education intervention for TKA patients

  • BehavioralRoutine Education

    Carry out routine education intervention for TKA patients

06

What researchers measure

Primary outcomes

  1. Visual analogue scale pain score, (VAS)

    Status of pain

    Time frame: 3 months after discharge

07

Study locations

1 site
  • Yongmei Zhang
    Zunyi, Guizhou 563000, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05915650
Lead sponsor
Zunyi Medical College
Responsible party
Yongmei Zhang (Study Director, Zunyi Medical College) — Principal investigator
First posted
Jun 23, 2023
Start date
Dec 1, 2020
Primary completion
Dec 1, 2021
Completion
Dec 1, 2021
Last update
Jun 23, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Pain, Postoperative→

Other studies from this sponsor

Zunyi Medical College

Start the discussion